HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xue Gong Selected Research

G-Protein-Coupled Receptor Kinase 4

10/2021Genetic variants of GRK4 influence circadian rhythm of blood pressure and response to candesartan in hypertensive patients.
1/2021The role of G protein-coupled receptor kinase 4 in cardiomyocyte injury after myocardial infarction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xue Gong Research Topics

Disease

36Neoplasms (Cancer)
03/2022 - 09/2008
7Encephalitis (Encephalitis, Rasmussen)
01/2022 - 01/2019
6Breast Neoplasms (Breast Cancer)
09/2020 - 01/2017
5Heart Failure
06/2021 - 04/2017
5Carcinogenesis
09/2020 - 04/2010
4Carcinoma (Carcinomatosis)
01/2022 - 01/2018
4Neoplasm Metastasis (Metastasis)
04/2021 - 05/2017
3Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2022 - 01/2021
3Epilepsy (Aura)
01/2022 - 01/2020
3Hypoxia (Hypoxemia)
01/2022 - 01/2021
3Glioma (Gliomas)
01/2022 - 11/2020
3Human Influenza (Influenza)
08/2021 - 12/2014
3Metabolic Diseases (Metabolic Disease)
07/2020 - 01/2017
3Body Weight (Weight, Body)
01/2017 - 01/2011
2Myopia
10/2022 - 09/2022
2Rupture
07/2022 - 03/2021
2Leiomyoma (Uterine Fibroids)
05/2022 - 01/2021
2Vascular Remodeling
01/2022 - 12/2021
2Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2022 - 12/2019
2Hypertension (High Blood Pressure)
10/2021 - 01/2021
2Communicable Diseases (Infectious Diseases)
08/2021 - 02/2013
2Fibrosis (Cirrhosis)
06/2021 - 04/2017
2Inflammation (Inflammations)
04/2021 - 01/2012
2Myocardial Infarction
04/2021 - 01/2021
2Ischemic Stroke
04/2021 - 01/2021
2Wounds and Injuries (Trauma)
12/2020 - 12/2018
2Lung Neoplasms (Lung Cancer)
09/2020 - 01/2015
2Urinary Bladder Neoplasms (Bladder Cancer)
12/2019 - 09/2017
2Pain (Aches)
01/2019 - 01/2019
2Prostatic Neoplasms (Prostate Cancer)
05/2017 - 09/2015
2Liver Diseases (Liver Disease)
01/2017 - 12/2013
2Glioblastoma (Glioblastoma Multiforme)
01/2012 - 01/2011
2Atrioventricular Block
04/2010 - 04/2009
1Placenta Previa
07/2022
1Anemia
07/2022
1Threatened Abortion
07/2022
1Spontaneous Abortion (Miscarriage)
07/2022
1Preterm Premature Rupture of the Membranes
07/2022
1Burkitt Lymphoma (Burkitt's Lymphoma)
05/2022
1Hemoptysis
01/2022
1Infections
01/2022
1Weight Loss (Weight Reduction)
01/2022

Drug/Important Bio-Agent (IBA)

14MicroRNAs (MicroRNA)IBA
01/2022 - 01/2011
11Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2010
11Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2015
10Pharmaceutical PreparationsIBA
01/2022 - 07/2014
7N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2022 - 01/2019
7DNA (Deoxyribonucleic Acid)IBA
12/2021 - 09/2015
5Biological ProductsIBA
12/2021 - 09/2008
4Long Noncoding RNAIBA
01/2022 - 03/2017
4Transcription Factors (Transcription Factor)IBA
11/2018 - 01/2011
3EnzymesIBA
12/2021 - 02/2016
3Catalytic DNA (Deoxyribozyme)IBA
12/2021 - 11/2020
3Therapeutic UsesIBA
11/2021 - 01/2019
3RNA (Ribonucleic Acid)IBA
12/2019 - 09/2015
2Retinaldehyde (Retinal)IBA
09/2022 - 11/2017
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2022 - 01/2022
2Leucine (L-Leucine)FDA Link
01/2022 - 01/2022
2Aminobutyrates (Aminobutyric Acid)IBA
01/2022 - 11/2020
2CateninsIBA
01/2022 - 01/2020
2HLA-DRB1*03:01 antigenIBA
01/2022 - 01/2020
2HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 01/2020
2Circular RNAIBA
12/2021 - 01/2019
2G-Protein-Coupled Receptor Kinase 4IBA
10/2021 - 01/2021
2CollagenIBA
06/2021 - 06/2021
2Liposomes (Liposome)IBA
06/2021 - 04/2021
2gamma-Aminobutyric Acid (GABA)IBA
01/2021 - 12/2015
2ProdrugsIBA
01/2021 - 11/2020
2CytokinesIBA
01/2021 - 04/2017
2acridoneIBA
01/2021 - 01/2020
2NanocapsulesIBA
01/2021 - 11/2020
2TamoxifenFDA LinkGeneric
02/2020 - 01/2017
2Phenobarbital (Luminal)FDA Link
12/2019 - 01/2018
2Phosphotransferases (Kinase)IBA
12/2019 - 01/2015
2Mitogen-Activated Protein KinasesIBA
12/2019 - 07/2014
2LipidsIBA
01/2019 - 01/2011
2GATA Transcription FactorsIBA
12/2018 - 01/2018
2Sucrose (Saccharose)IBA
02/2018 - 01/2017
2Dichlorodiphenyldichloroethane (DDD)IBA
04/2010 - 04/2009
1melanopsinIBA
10/2022
1Dopamine (Intropin)FDA LinkGeneric
09/2022
1MelatoninIBA
09/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2022
1ProgesteroneFDA LinkGeneric
07/2022
1Rituximab (Mabthera)FDA Link
05/2022
1Propranolol (Inderal)FDA LinkGeneric
03/2022
1Prednisolone (Predate)FDA LinkGeneric
01/2022
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2022
1MethylprednisoloneFDA LinkGeneric
01/2022
1Valproic Acid (Depakote)FDA LinkGeneric
01/2022
1Semaxinib (SU5416)IBA
01/2022
1Anti-Idiotypic AntibodiesIBA
01/2022

Therapy/Procedure

16Therapeutics
02/2022 - 01/2012
5Immunotherapy
01/2022 - 07/2018
3Drug Therapy (Chemotherapy)
05/2022 - 02/2018
3Minimally Invasive Surgical Procedures
02/2022 - 01/2021
3Cardiac Resynchronization Therapy
06/2021 - 04/2017
2High-Intensity Focused Ultrasound Ablation
05/2022 - 01/2021
2Chemoradiotherapy
02/2022 - 07/2018
2Percutaneous Coronary Intervention
12/2021 - 01/2021